lentiCRISPRv2-Blast-mU6
(Plasmid
#206806)
-
Purpose(Empty Backbone) pLentiCRISPRv2 variant with mU6 promoter driving the sgRNA, and a Blasticidin resistance cassette
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 206806 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonelentiCRISPR v2-Blast
-
Backbone manufacturerMohan Babu
- Backbone size (bp) 14684
-
Modifications to backboneAmplified mU6 promoter from plasmid pmU6-gRNA (Addgene Plasmid #53187) and replaced the hU6 promoter in lentiCRISPRv2-Blast (Addgene Plasmid #83480) with mU6 promoter by restriction-ligation. Verified by Sanger sequencing.
-
Vector typeMammalian Expression, Lentiviral, CRISPR
- Promoter mU6
-
Selectable markersBlasticidin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Cloning Information
- Cloning method Restriction Enzyme
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byThe mU6 promoter was amplified from a plasmid obtained from Addgene (Plasmid #53187). The backbone was purchased from Addgene (Plasmid #83480).
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
lentiCRISPRv2-Blast-mU6 was a gift from Jolanda Van Leeuwen (Addgene plasmid # 206806 ; http://n2t.net/addgene:206806 ; RRID:Addgene_206806) -
For your References section:
Global analysis of suppressor mutations that rescue human genetic defects. Unlu B, Pons C, Ho UL, Batte A, Aloy P, van Leeuwen J. Genome Med. 2023 Oct 12;15(1):78. doi: 10.1186/s13073-023-01232-0. 10.1186/s13073-023-01232-0 PubMed 37821946